Hyperhomocysteinemia and atherosclerosis;Hiperhomocysteinemia i jej zwia+ (combining ogonek sign)zek z miażdżyca+ (combining ogonek sign) te+ (combining ogonek sign)tnic

Polskie Archiwum Medycyny Wewnetrznej

Volumn 98, Issue 2, 1997, Pages 153-162

  Domagała, Barbara ^a   Sanak, Marek ^a   Czachór, Renata ^a   Szczeklik, Andrzej ^a  

^a UJ   (Poland)

Author keywords

Atherosclerosis; Folic acid; Hyperhomocysteinemia

Indexed keywords

EID: 2442636744     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mayer E.L., Jacobsen D. W., Robinson K.: Homocysteine and coronary atherosclerosis. JACC, 1996, 27, 517.
2. Gupta V.J., Wilcken D.E.L.: Detection of cysteine-homocysteine mixed disulphide in plasma of normal fasting man. Eur. J. Clin. Invest., 1978, 8, 205.
3. Refsum H., Helland S., Ueland P.M.: Radioenzymic determination of homocysteine in plasma and urine. Clin. Chem., 1985, 31, 624.
4. Malinow M.R., Kang S.S., Taylor L.M. i wsp.: Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation, 1989, 79, 1180.
5. Alfthan G., Pekkanen J., Jauhiainen M. i wsp.: Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis, 1994, 106, 9.
6. Wang J., Dudman N.P.B., Wicken D.E.L., Homocysteine catabolism: levels of enzymes in cultured human vasculat endothelial cells and their relevance to vascular diesease. Atherosclerosis, 1992, 97, 97.
7. Peytreman R., Thorndyke J., Beck W.S.: Studies on N5-methyl-tetrahydrofalate: homocysteine methyltransferase in normal and leukemic lymphocytes. J. Clin. Invest., 1975, 56, 1293.
8. Kang S.S., Wong P.W.K., Susmano A., Sora J., Norusis M., Ruggie N.: Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am. J. Hum. Genet., 1991, 48, 536.
9. Goyette P., Summer J.S., Milos R. i wsp.: Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet., 1994, 7, 195.
10. Frosst P., Blom H.J., Milos R. i wsp.: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet., 1995, 10, 111.
11. Rozen R.: Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin. Invest. Med., 1996, 19, 171.
12. Peng F., Triplett D., Barna L., Morrical D.: Pulmonary embolism and premature labor in a patient with both factor V Leiden mutation and methyleneterahydrofolate reductase gene C677T mutation. Thromb. Res., 1996, 83, 243.
13. McAndrew P.E., Brant J.T., Pearl D.K., Prior T.W.: The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in Africans Amencians. Thromb. Res., 1996, 83, 195.
14. Domagala T.B., Libura M., Gozdecka H., Krzanowski M., Szczeklik A.: Rodzinna hiperhomocysteinemia przebiegaja+ (combining ogonek sign)ca z wczesna+ (combining ogonek sign) miażdżyca+ (combining ogonek sign) te+ (combining ogonek sign)tnic. Pol. Arch. Med. Wewn., 1996, 96, 354.
15. Gallagher P.M., Ward P., Tan S. i wsp.: High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients. Human Mut., 1995, 6, 177.
16. Kluijtmans L.A.J., Lambert P.W.J., van den Heuvel L.P.W.J. i wsp.: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet., 1996, 58, 35.
17. Kang SsS., Wong P.W.L., Malinow M.R.: Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr., 1992, 12. 279.
18. Mundd S.H., Levy H.L., Skovy F.: Disorders of transsulfuration. In: The metabolic and molecular bases of inherited disease (Scriver C.R., Beaudet A.L., Sly W.S., & Valle D., ed.). McGraw Hill, New York, N.Y. 1995, 1279.
19. Kang S.S., Wong P.W.K., Morasis M.: Homocysteinemia due to folate deficiency. Metabolism, 1987, 36, 458.
20. 12 deficiency than in heterozigosity for cystathionine β-syntase deficiency. Metabolism, 1988, 37, 175.
21. Brattstrom L., Israelsson B., Norving B. i wsp.: Impared homocysteine metabolism in early onset cerebral and perihperal occlusive arterial disease. Atherosclerosis, 1990, 81, 51.
22. McCully K.S.: Vascular pathology of homocysteinemia: implications for pathogenesis of atherosclerosis. Am. J. Pathol., 1969, 56, 111.
23. Mudd H.S., Levy H.L., Skovby F.: Disorders of transsulfuration. In: Scriver C.S., Beaudet A.L., Sly W.L., Valle D. (ed). The metabolic basis of inherited disease. New York: McGraw - Hill Books, 1989, 693.
24. McCully K.S.: Zaburzenia przemian homocysteiny a aterogeneza. Czynniki Ryzyka, 1994, 2/3, 26.
25. Arnesen E., Refsum H., Bonaa K.H. i wsp.: Serum total homocysteine and coronary heart disease. Intern. J. Epidem., 1995, 24, 704.
26. Clarke R., Kaly L., Robinson K. i wsp.: Hyperhomocystememia: an independent risk factor for vascular disease. N. Engl. J. Med., 1991, 324, 1149.
27. Boers G.H.J., Smals A.G., Trijbels F.J. i wsp.: heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med., 1985, 313. 709.
28. Boushey C.J., Beresford S.A.A., Gilbert S.O., Motulsky A.G.-A quantitative assesment of plasma homocysteine as a risk factor for vacular disease. JAMA, 1995, 274, 1049.
29. Nygard O., Vollset S.E., Refsum H. i wsp.: Total homocysteine and cardiovascular risk profile: The Hordaland homocysteine study. JAMA, 1995, 274, 1526.
30. Starkebaum G., Harlan J.M.: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest., 1986, 77, 1370.
31. Panganamala R.V., Karpen C.W., Merola A.J.: Peroxide mediated effects of homocysteine on arterial prostacyclin syntesis. Prostaglandins Leukotrienes Med., 1986, 22, 349.
32. Wang J., Dudman N.P.B., Wilcken D.E.L.: Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelin cells. Thromb. Haemost., 1993, 70, 1047.
33. Harker L.A., Slichter S.J., Scott C.R., Ross R.: Homocysteinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med., 1974, 291, 537.
34. Harker L.A., Harlan J.M., Ross R.: Effects of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Cir. Res., 1983, 53, 731.
35. Uhlemann E.R., TenPas J.H., Lucky A.W., Schulman J.D., Mudd S.H., Shulman N.R.: Platelet survival and morphology in homocystinuria due to cystathionine synthase deficency. N. Engl. J. Med., 1976, 295, 1283.
36. 111indium-labeled platelets in patients with homocystinuria. N. Engl. J. Med., 1982, 307, 78.
37. Hilden M., Brandt N.J., Nilsson I.M., Schonheyder F.: Investigation of coagulation and fibrinolysis in homocystinuria. Acta Med. Scand., 1974, 195, 533.
38. Rodgers G.M., Conn M.T.: Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood, 1990, 75, 895.
39. Lentz S.R., Sadler J.E.: Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest., 1991, 88, 1906.
40. Witztum J.L., Steinberg D.: Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest., 1991, 88, 1785.
41. Naruszewicz M., Mirkiewicz E., Olszewski A.J., McCully K.S.: Tiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutr. Metab. Cardiovasc. Dis., 1994, 4, 70.
42. Heinecke J. W., Kawamura M., Suzuki L., Chain A.: Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanism. J. Lipid Res., 1993, 34, 2051.
43. Horano K., Ogihara T., Miki M. i wsp.: Homocysteine induced iron-catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol, Free Rad. Res., 1994, 21, 267-276.
44. Domagala T.B., Libura M., Szczeklik A.: Hyperhomocysteinemia following oral methonine load is associated with increased lipid peroxidation. Thromb. Res., (w druku).
45. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H.: Vitamin status and intake as primary determinate of homocysteinemia in an eldery population, JAMA, 1993, 270, 2693.